Ninety One (UK)
BIIB icon

Ninety One (UK)’s Biogen BIIB Stock Holding History

Ninety One (UK)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-188
Closed -$40.6K – 335
2026
Q2 		$40.6K Buy
+188
New +$36K ﹤0.01% 254

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Beau Ventures, LLc
Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Adams Diversified Equity Fund
Adams Diversified Equity Fund Baltimore, Maryland $3.3B AUM 38.12% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
North Growth Management
North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

Ninety One (UK)'s BIIB Position: Q3 2026 in Review

Ninety One (UK) sold out of Biogen (BIIB) in Q3 2026, closing a stake of 188 shares — an estimated $40.6K sold.

Ninety One (UK) first reported a position in BIIB in Q2 2026 and held it in 1 quarter. The position peaked at $40.6K in Q2 2026. 232 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Ninety One (UK) reported no remaining Biogen position as of Q3 2026 after selling out during the quarter.
  • Ninety One (UK) sold 188 Biogen shares in Q3 2026, an estimated $40.6K.
  • Ninety One (UK) first reported a position in Biogen in Q2 2026 and held it in 1 quarter.
  • Ninety One (UK)'s Biogen position peaked at $40.6K in Q2 2026.
  • 232 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Ninety One (UK)'s 13F filing for Q3 2026, filed 15 Oct 2026.